Insulet Co. (NASDAQ:PODD) Stock Position Trimmed by abrdn pl

abrdn plc cut its position in Insulet Co. (NASDAQ:PODD – Free Report) by 3.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 305,354 shares of the medical instruments supplier’s stock after selling 11,574 shares during the quarter. abrdn plc owned about […]

Related Keywords

Piper Sandler , Stifel Nicolaus , Shacey Petrovic , Barclays , Geode Capital Management , Jpmorgan Chase Co , William Blair Investment Management , Nasdaq , Insulet Corporation , Securities Exchange Commission , Insulet Company Profile , Insulet Co , Baillie Gifford Co , Moneta Group Investment Advisors , Clearbridge Investments , Free Report , Group Investment Advisors , Capital Management , Blair Investment Management , Director Shacey Petrovic , Exchange Commission , Get Free Report , Insulin Delivery System , Personal Diabetes Manager , Insulet Daily , Insulet , Nasdaq Podd , Podd , Medical , 45784p10 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,